EXCLUDIF Trademark

Trademark Overview


On Wednesday, December 18, 2019, a trademark application was filed for EXCLUDIF with the United States Patent and Trademark Office. The USPTO has given the EXCLUDIF trademark a serial number of 88731270. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2022. This trademark is owned by Seres Therapeutics, Inc.. The EXCLUDIF trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely for the treatment of dysbiosis; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent and treat dysbiosis and other medical conditions resulting from a disturbed microbial community
excludif

General Information


Serial Number88731270
Word MarkEXCLUDIF
Filing DateWednesday, December 18, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2020

Trademark Statements


Goods and ServicesPharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely for the treatment of dysbiosis; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent and treat dysbiosis and other medical conditions resulting from a disturbed microbial community

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSeres Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameSeres Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Monday, July 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, December 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 8, 2021SOU EXTENSION 2 GRANTED
Wednesday, December 8, 2021SOU EXTENSION 2 FILED
Wednesday, December 8, 2021TEAS EXTENSION RECEIVED
Saturday, June 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 10, 2021SOU EXTENSION 1 GRANTED
Thursday, June 10, 2021SOU EXTENSION 1 FILED
Thursday, June 10, 2021TEAS EXTENSION RECEIVED
Tuesday, December 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 27, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NON-FINAL ACTION WRITTEN
Tuesday, March 17, 2020ASSIGNED TO EXAMINER
Saturday, December 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 21, 2019NEW APPLICATION ENTERED IN TRAM